SCHEMBL3708036

SCHEMBL3708036

CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.56
DPP8 Q6V1X1 2/20 0.56
DPP9 Q86TI2 2/20 0.56
ENPEP Q07075 10/20 0.53
ALDH1A1 P00352 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.48
GRM8 O00222 1/20 0.47
GRM6 O15303 1/20 0.47
GRIN2D O15399 1/20 0.47
GRIN3B O60391 1/20 0.47
GSR P00390 1/20 0.47
CYP1A2 P05177 1/20 0.47
GRIK1 P39086 1/20 0.47
GRM5 P41594 1/20 0.47
GRIA1 P42261 1/20 0.47
GRIA2 P42262 1/20 0.47
GRIA3 P42263 1/20 0.47
SLC1A3 P43003 1/20 0.47
SLC1A2 P43004 1/20 0.47
SLC1A1 P43005 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3708037 1.00 DPP4 (0.56) DPP4DPP8DPP9ENPEPALDH1A1
SCHEMBL29893089 0.93 ENPEP (0.51) DPP4DPP8DPP9ENPEPALDH1A1
SCHEMBL11886063 0.93 ENPEP (0.54) DPP4DPP8DPP9ENPEPALDH1A1
SCHEMBL29400621 0.93 ENPEP (0.54) DPP4DPP8DPP9ENPEPALDH1A1
SCHEMBL29458837 0.93 ENPEP (0.54) DPP4DPP8DPP9ENPEPALDH1A1
SCHEMBL29892607 0.92 ENPEP (0.53) DPP4DPP8DPP9ENPEPALDH1A1
SCHEMBL29366194 0.92 ENPEP (0.62) DPP4DPP8DPP9ENPEPBACE1
SCHEMBL30685382 0.91 ENPEP (0.55) DPP4DPP8DPP9ENPEPBACE1
SCHEMBL31151771 0.89 ENPEP (0.60) DPP4DPP8DPP9ENPEPBACE1
SCHEMBL3708040 0.89 DPP4 (0.55) DPP4DPP8DPP9ENPEPALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4659591-A1 TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT House Foods Group Inc. (JP) 2025-12-10 EP claimed
WO-2024162422-A1 TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT ハウス食品グループ本社株式会社 2024-08-08 WO claimed
CN-116925188-A Synthesis method of polypeptide and derivative thereof for preventing or treating coronavirus 深圳翰宇药业股份有限公司 2023-10-24 CN claimed
WO-2022181712-A1 COMPOSITION CONTAINING DECOMPOSED PRODUCTS OF VEGETABLE PROTEIN AND METHOD FOR PRODUCING SAME 株式会社Mizkan Holdings 2022-09-01 WO claimed
CN-114032271-A Oyster polypeptide and polypeptide powder with uric acid reducing effect as well as preparation method and application of oyster polypeptide and polypeptide powder 浙江工业大学 2022-02-11 CN claimed
EP-3554267-A1 COMPOSITIONS AND METHODS FOR SMALL CANINES Société des Produits Nestlé S.A. (CH) 2019-10-23 EP claimed
WO-2018109672-A1 COMPOSITIONS AND METHODS FOR SMALL CANINES NESTEC SA (CH) 2018-06-21 WO claimed
EP-3129909-A1 SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT Metabolon, Inc. (US) 2017-02-15 EP claimed
WO-2015157407-A1 SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT METABOLON, INC. (US) 2015-10-15 WO claimed
CN-119709844-B Application of rice gene OsbHLH176,176 in regulation and control of cold resistance 南京农业大学 2026-05-15 CN disclosed
EP-4659591-A1 TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT House Foods Group Inc. (JP) 2025-12-10 EP disclosed
US-20250360169-A1 EXTRACELLULAR VESICLES AND METHODS OF USING NUTECH VENTURES (US) 2025-11-27 US disclosed
US-12290533-B2 Extracellular vesicles and methods of using NUTECH VENTURES (US) 2025-05-06 US disclosed
CN-119709844-A Application of rice gene OsbHLH176,176 in regulation and control of cold resistance 南京农业大学 2025-03-28 CN disclosed
US-8658351-B2 Determining liver toxicity of an agent using metabolite biomarkers METABOLON, INC. (US) 2014-02-25 US disclosed
WO-2013155528-A2 METHODS FOR REDUCING BRAIN INFLAMMATION, INCREASING INSULIN SENSITIVITY, AND REDUCING CERAMIDE LEVELS FASGEN, INC. (US) 2013-10-17 WO disclosed
US-7846902-B2 Dipeptide-comprising composition for oral administration KYOWA HAKKO BIO CO., LTD. (JP) 2010-12-07 US disclosed
WO-2010091290-A1 DETERMINATION OF THE LIVER TOXICITY OF AN AGENT METABOLON, INC. (US) 2010-08-12 WO disclosed
US-20080305151-A1 Dipeptide-Comprising Composition for Oral Administration KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-12-11 US disclosed
EP-1941896-A1 DIPEPTIDE-CONTAINING COMPOSITION FOR ORAL ADMINISTRATION KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-07-09 EP disclosed